635 results on '"Mahnken, Jonathan"'
Search Results
2. Long-Term Engagement in Smoking Cessation Counseling among Rural Smokers
- Author
-
Cupertino, A. Paula, Mahnken, Jonathan D, Richter, Kimber, Cox, Lisa Sanderson, Casey, Genevieve, Resnicow, Ken, and Ellerbeck, Edward F
- Published
- 2007
- Full Text
- View/download PDF
3. Changes in Cognitive Function After Kidney Transplantation: A Longitudinal Cohort Study
- Author
-
Gupta, Aditi, Mahnken, Jonathan D., Bernal, Joshua, Sharma, Palash, Lepping, Rebecca J., Montgomery, Robert N., Johnson, David K., Parks, Adam, Burns, Jeffrey M., Drew, David A., Sarnak, Mark J., and Brooks, William M.
- Published
- 2024
- Full Text
- View/download PDF
4. Design of a pragmatic randomized implementation effectiveness trial testing a health system wide hypertension program for older adults
- Author
-
Gupta, Aditi, Chouhdry, Hira, Ellis, Shellie D., Young, Kate, Mahnken, Jonathan, Comfort, Branden, Shanks, Denton, McGreevy, Sheila, Rudy, Courtney, Zufer, Tahira, Mabry, Sharissa, Woodward, Jennifer, Wilson, Amber, Anderson, Heidi, Loucks, Jennifer, Chandaka, Sravani, Abu-el-rub, Noor, Mazzotti, Diego R., Song, Xing, Schmitz, Nolan, Conroy, Molly, Supiano, Mark A., Waitman, Lemuel R., and Burns, Jeffrey M.
- Published
- 2024
- Full Text
- View/download PDF
5. Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer’s: A 1-year randomized controlled trial
- Author
-
Vidoni, Eric D, Morris, Jill K, Watts, Amber, Perry, Mark, Clutton, Jon, Van Sciver, Angela, Kamat, Ashwini S, Mahnken, Jonathan, Hunt, Suzanne L, Townley, Ryan, Honea, Robyn, Shaw, Ashley R, Johnson, David K, Vacek, James, and Burns, Jeffrey M
- Subjects
Biomedical and Clinical Sciences ,Biological Psychology ,Clinical Sciences ,Health Sciences ,Psychology ,Behavioral and Social Science ,Aging ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Neurosciences ,Brain Disorders ,Alzheimer's Disease ,Acquired Cognitive Impairment ,Clinical Trials and Supportive Activities ,Clinical Research ,Prevention ,Biomedical Imaging ,Neurodegenerative ,Dementia ,Mental Health ,Neurological ,Aged ,Alzheimer Disease ,Amyloid ,Brain ,Exercise ,Female ,Humans ,Magnetic Resonance Imaging ,Male ,General Science & Technology - Abstract
BackgroundOur goal was to investigate the role of physical exercise to protect brain health as we age, including the potential to mitigate Alzheimer's-related pathology. We assessed the effect of 52 weeks of a supervised aerobic exercise program on amyloid accumulation, cognitive performance, and brain volume in cognitively normal older adults with elevated and sub-threshold levels of cerebral amyloid as measured by amyloid PET imaging.Methods and findingsThis 52-week randomized controlled trial compared the effects of 150 minutes per week of aerobic exercise vs. education control intervention. A total of 117 underactive older adults (mean age 72.9 [7.7]) without evidence of cognitive impairment, with elevated (n = 79) or subthreshold (n = 38) levels of cerebral amyloid were randomized, and 110 participants completed the study. Exercise was conducted with supervision and monitoring by trained exercise specialists. We conducted 18F-AV45 PET imaging of cerebral amyloid and anatomical MRI for whole brain and hippocampal volume at baseline and Week 52 follow-up to index brain health. Neuropsychological tests were conducted at baseline, Week 26, and Week 52 to assess executive function, verbal memory, and visuospatial cognitive domains. Cardiorespiratory fitness testing was performed at baseline and Week 52 to assess response to exercise. The aerobic exercise group significantly improved cardiorespiratory fitness (11% vs. 1% in the control group) but there were no differences in change measures of amyloid, brain volume, or cognitive performance compared to control.ConclusionsAerobic exercise was not associated with reduced amyloid accumulation in cognitively normal older adults with cerebral amyloid. In spite of strong systemic cardiorespiratory effects of the intervention, the observed lack of cognitive or brain structure benefits suggests brain benefits of exercise reported in other studies are likely to be related to non-amyloid effects.Trial registrationNCT02000583; ClinicalTrials.gov.
- Published
- 2021
6. Longitudinal Changes in, and Factors Associated with, the Frequency of Condomless Sex Among People in Care for HIV Infection, HIV Outpatient Study USA, 2007–2019
- Author
-
Durham, Marcus D., Armon, Carl, Novak, Richard M., Mahnken, Jonathan D., Carlson, Kimberly, Li, Jun, and Buchacz, Kate
- Published
- 2022
- Full Text
- View/download PDF
7. Trajectories of glycemic control with clinical pharmacy specialist management of veterans with type 2 diabetes
- Author
-
Grabarczyk, Ted R., Roberts, Andrew W., Mahnken, Jonathan D., and Grauer, Dennis
- Published
- 2022
- Full Text
- View/download PDF
8. EEG/ERP evidence of possible hyperexcitability in older adults with elevated beta-amyloid
- Author
-
Devos, Hannes, Gustafson, Kathleen, Liao, Ke, Ahmadnezhad, Pedram, Estes, Bradley, Martin, Laura E., Mahnken, Jonathan D., Brooks, William M., and Burns, Jeffrey M.
- Published
- 2022
- Full Text
- View/download PDF
9. Discrepancies between Perceived and Measured Cognition in Kidney Transplant Recipients: Implications for Clinical Management.
- Author
-
Gupta, Aditi, Thomas, Tashra S, Klein, Jeffrey A, Montgomery, Robert N, Mahnken, Jonathan D, Johnson, David K, Drew, David A, Sarnak, Mark J, and Burns, Jeffrey M
- Subjects
Humans ,Kidney Transplantation ,Reproducibility of Results ,Cognition ,Neuropsychological Tests ,Quality of Life ,Adult ,Aged ,Middle Aged ,Nurses ,Physicians ,Case Management ,Female ,Male ,Transplant Recipients ,Cognitive Dysfunction ,Cognitive impairment ,Kidney transplant ,Montreal Cognitive Assessment ,Transplantation ,Kidney Disease ,Basic Behavioral and Social Science ,Clinical Trials and Supportive Activities ,Organ Transplantation ,Acquired Cognitive Impairment ,Brain Disorders ,Clinical Research ,Behavioral and Social Science ,Clinical Sciences ,Medical Physiology ,Urology & Nephrology - Abstract
BackgroundCognitive impairment is common in kidney transplant (KT) recipients and affects quality of life, graft survival, morbidity, and mortality. Failure to identify patients with cognitive impairment can withhold appropriate and timely intervention. This study determines whether measured cognition with standard screening tools offers any advantage over perceived cognition in screening transplant patients for cognitive impairment.MethodsCognition was assessed in 157 KT recipients using the Montreal Cognitive Assessment (MoCA; measured cognition). In addition, transplant physicians and nurse coordinators were asked to rate transplant recipients' level of cognition after routine clinical interactions (perceived cognition). Physicians and nurses were blind to MoCA scores. Perceived cognition scores were compared to MoCA scores.ResultsPerceived cognition scores fairly correlated with MOCA scores (γ = 0.24, p = 0.001 for physicians and γ = 0.33, p < 0.0001 for nurses). Physician scores moderately correlated with nurses scores (κ = 0.44, p < 0.0001). Clinical perception had a low accuracy for identifying patients with cognitive impairment (sensitivity 66% for physicians, 65% for nurses), and those without cognitive impairment (specificity 67% for physicians, 76% for nurses).ConclusionClinical perception is inaccurate at detecting cognitive impairment in KT recipients. Objective tests should be considered to screen KT recipients for cognitive impairment.
- Published
- 2018
10. Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
- Author
-
El Ters, Mireille, Lu, Pengcheng, Mahnken, Jonathan D., Stubbs, Jason R., Zhang, Shiqin, Wallace, Darren P., Grantham, Jared J., Chapman, Arlene B., Torres, Vicente E., Harris, Peter C., Bae, Kyongtae Ty, Landsittel, Douglas P., Rahbari-Oskoui, Frederic F., Mrug, Michal, Bennett, William M., and Yu, Alan S.L.
- Published
- 2021
- Full Text
- View/download PDF
11. Prevalence and correlates of cognitive impairment in kidney transplant recipients.
- Author
-
Gupta, Aditi, Mahnken, Jonathan D, Johnson, David K, Thomas, Tashra S, Subramaniam, Dipti, Polshak, Tyler, Gani, Imran, John Chen, G, Burns, Jeffrey M, and Sarnak, Mark J
- Subjects
Humans ,Kidney Failure ,Chronic ,Diabetes Mellitus ,Glomerular Filtration Rate ,Kidney Transplantation ,Prevalence ,Risk Factors ,Cross-Sectional Studies ,Causality ,Comorbidity ,Age Distribution ,Sex Distribution ,Middle Aged ,Educational Status ,Kansas ,Female ,Male ,Cognitive Dysfunction ,Cognitive impairment ,Kidney transplantation ,MoCA ,Kidney Disease ,Aging ,Clinical Research ,Behavioral and Social Science ,Transplantation ,Acquired Cognitive Impairment ,Organ Transplantation ,Brain Disorders ,Aetiology ,2.3 Psychological ,social and economic factors ,Renal and urogenital ,Clinical Sciences ,Urology & Nephrology - Abstract
BackgroundThere is a high prevalence of cognitive impairment in dialysis patients. The prevalence of cognitive impairment after kidney transplantation is unknown.MethodsStudy Design: Cross-sectional study.Setting and participantsSingle center study of prevalent kidney transplant recipients from a transplant clinic in a large academic center.InterventionAssessment of cognition using the Montreal Cognitive Assessment (MoCA). Demographic and clinical variables associated with cognitive impairment were also examined. Outcomes and Measurements: a) Prevalence of cognitive impairment defined by a MoCA score of
- Published
- 2017
12. Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial.
- Author
-
Morris, Jill K, Vidoni, Eric D, Johnson, David K, Van Sciver, Angela, Mahnken, Jonathan D, Honea, Robyn A, Wilkins, Heather M, Brooks, William M, Billinger, Sandra A, Swerdlow, Russell H, and Burns, Jeffrey M
- Subjects
Humans ,Alzheimer Disease ,Exercise ,Exercise Therapy ,Pilot Projects ,Memory ,Aged ,Aged ,80 and over ,Female ,Male ,Executive Function ,Cardiorespiratory Fitness ,Depression ,Clinical Research ,Clinical Trials and Supportive Activities ,Prevention ,Neurodegenerative ,Neurosciences ,Brain Disorders ,Acquired Cognitive Impairment ,Alzheimer's Disease ,Aging ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Mental Health ,Dementia ,Behavioral and Social Science ,6.7 Physical ,Evaluation of treatments and therapeutic interventions ,Neurological ,Mental health ,Good Health and Well Being ,General Science & Technology - Abstract
BackgroundThere is increasing interest in the role of physical exercise as a therapeutic strategy for individuals with Alzheimer's disease (AD). We assessed the effect of 26 weeks (6 months) of a supervised aerobic exercise program on memory, executive function, functional ability and depression in early AD.Methods and findingsThis study was a 26-week randomized controlled trial comparing the effects of 150 minutes per week of aerobic exercise vs. non-aerobic stretching and toning control intervention in individuals with early AD. A total of 76 well-characterized older adults with probable AD (mean age 72.9 [7.7]) were enrolled and 68 participants completed the study. Exercise was conducted with supervision and monitoring by trained exercise specialists. Neuropsychological tests and surveys were conducted at baseline,13, and 26 weeks to assess memory and executive function composite scores, functional ability (Disability Assessment for Dementia), and depressive symptoms (Cornell Scale for Depression in Dementia). Cardiorespiratory fitness testing and brain MRI was performed at baseline and 26 weeks. Aerobic exercise was associated with a modest gain in functional ability (Disability Assessment for Dementia) compared to individuals in the ST group (X2 = 8.2, p = 0.02). There was no clear effect of intervention on other primary outcome measures of Memory, Executive Function, or depressive symptoms. However, secondary analyses revealed that change in cardiorespiratory fitness was positively correlated with change in memory performance and bilateral hippocampal volume.ConclusionsAerobic exercise in early AD is associated with benefits in functional ability. Exercise-related gains in cardiorespiratory fitness were associated with improved memory performance and reduced hippocampal atrophy, suggesting cardiorespiratory fitness gains may be important in driving brain benefits.Trial registrationClinicalTrials.gov NCT01128361.
- Published
- 2017
13. Biological Efficacy and Safety of Niacinamide in Patients With ADPKD
- Author
-
El Ters, Mireille, Zhou, Xia, Lepping, Rebecca J., Lu, Pengcheng, Karcher, Rainer T., Mahnken, Jonathan D., Brooks, William M., Winklhofer, Franz T., Li, Xiaogang, and Yu, Alan S.L.
- Published
- 2020
- Full Text
- View/download PDF
14. Rates of suicidal ideation among HIV-infected patients in care in the HIV Outpatient Study 2000–2017, USA
- Author
-
Durham, Marcus D., Armon, Carl, Mahnken, Jonathan D., Novak, Richard M., Palella, Frank J., Jr, Tedaldi, Ellen, and Buchacz, Kate
- Published
- 2020
- Full Text
- View/download PDF
15. Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin.
- Author
-
Morris, Jill K, Vidoni, Eric D, Mahnken, Jonathan D, Montgomery, Robert N, Johnson, David K, Thyfault, John P, and Burns, Jeffrey M
- Subjects
Blood-Brain Barrier ,Humans ,Alzheimer Disease ,Insulin Resistance ,Insulin ,Glucose ,Risk Factors ,Cohort Studies ,Cognition Disorders ,Aged ,Female ,Male ,Memory ,Episodic ,Aging ,Alzheimer's disease ,Cognitive impairment ,Hyperinsulinemia ,Insulin resistance ,Acquired Cognitive Impairment ,Dementia ,Neurodegenerative ,Diabetes ,Clinical Research ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Neurosciences ,Alzheimer's Disease ,Brain Disorders ,Neurological ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
Insulin resistance is a risk factor for Alzheimer's disease (AD), although its role in AD etiology is unclear. We assessed insulin resistance using fasting and insulin-stimulated measures in 51 elderly subjects with no dementia (ND; n = 37) and with cognitive impairment (CI; n = 14). CI subjects exhibited either mild CI or AD. Fasting insulin resistance was measured using the homeostatic model assessment of insulin resistance (HOMA-IR). Insulin-stimulated glucose disposal was assessed using the hyperinsulinemic-euglycemic clamp to calculate glucose disposal rate into lean mass, the primary site of insulin-stimulated glucose disposal. Because insulin crosses the blood-brain barrier, we also assessed whether insulin infusion would improve verbal episodic memory compared to baseline. Different but equivalent versions of cognitive tests were administered in counterbalanced order in the basal and insulin-stimulated state. Groups did not differ in age or body mass index. Cognitively impaired subjects exhibited greater insulin resistance as measured at fasting (HOMA-IR; ND: 1.09 [1.1] vs. CI: 2.01 [2.3], p = 0.028) and during the hyperinsulinemic clamp (glucose disposal rate into lean mass; ND: 9.9 (4.5) vs. AD 7.2 (3.2), p = 0.040). Cognitively impaired subjects also exhibited higher fasting insulin compared to ND subjects, (CI: 8.7 [7.8] vs. ND: 4.2 [3.8] μU/mL; p = 0.023) and higher fasting amylin (CI: 24.1 [39.1] vs. 8.37 [14.2]; p = 0.050) with no difference in fasting glucose. Insulin infusion elicited a detrimental effect on one test of verbal episodic memory (Free and Cued Selective Reminding Test) in both groups (p < 0.0001) and no change in performance on an additional task (delayed logical memory). In this study, although insulin resistance was observed in cognitively impaired subjects compared to ND controls, insulin infusion did not improve memory. Furthermore, a significant correlation between HOMA-IR and glucose disposal rate was present only in ND (p = 0.0002) but not in cognitively impaired (p = 0.884) subjects, indicating potentially important physiological differences between these cohorts.
- Published
- 2016
16. A LEAP! FORWARD?: DOES PERSONALIZED EXERCISE HELP MAINTAIN COGNITIVE FUNCTION IN OLDER ADULTS?
- Author
-
Medina, Valerie, primary, Burns, Jeffrey M, additional, Vacek, James L, additional, Mahnken, Jonathan, additional, Clutton, Jonathan, additional, VanSciver, Angela, additional, and Watts, Amber, additional
- Published
- 2023
- Full Text
- View/download PDF
17. Lifestyle Empowerment for Alzheimer’s Prevention (LEAP! Rx) week 12 outcomes
- Author
-
Watts, Amber, primary, Van Sciver, Angela R, additional, Baker, Jordan, additional, Clutton, Jonathan, additional, Finley, Katrina, additional, Vacek, James, additional, Mahnken, Jonathan D, additional, and Burns, Jeffrey M., additional
- Published
- 2023
- Full Text
- View/download PDF
18. AD Biomarkers in Chronic Kidney Disease and Kidney Transplant
- Author
-
Gupta, Aditi, primary, Morris, Jill K, additional, Kueck, Paul J., additional, Blankenship, Anneka, additional, Mahnken, Jonathan D, additional, and Young, Kate, additional
- Published
- 2023
- Full Text
- View/download PDF
19. Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis
- Author
-
Jain, Nishank, Hunt, Suzanne L., Cui, Huizhong, Phadnis, Milind A., Mahnken, Jonathan D., Shireman, Theresa I., Dai, Junqiang, Mehta, Jawahar L., and Rasu, Rafia S.
- Published
- 2019
- Full Text
- View/download PDF
20. Estimator of Agreement with Covariate Adjustment
- Author
-
McKenzie, Katelyn A., primary and Mahnken, Jonathan D., additional
- Published
- 2023
- Full Text
- View/download PDF
21. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
- Author
-
Taylor, Matthew K., Sullivan, Debra K., Mahnken, Jonathan D., Burns, Jeffrey M., and Swerdlow, Russell H.
- Published
- 2018
- Full Text
- View/download PDF
22. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults
- Author
-
Taylor, Matthew K, Sullivan, Debra K, Swerdlow, Russell H, Vidoni, Eric D, Morris, Jill K, Mahnken, Jonathan D, and Burns, Jeffrey M
- Published
- 2017
- Full Text
- View/download PDF
23. Incidence of Hyperlipidemia among Adults Initiating Antiretroviral Therapy in the HIV Outpatient Study (HOPS), USA, 2007–2021.
- Author
-
Li, Jun, Agbobli-Nuwoaty, Selom, Palella, Frank J., Novak, Richard M., Tedaldi, Ellen, Mayer, Cynthia, Mahnken, Jonathan D., Hou, Qingjiang, Carlson, Kimberly, Thompson-Paul, Angela M., Durham, Marcus D., and Buchacz, Kate
- Abstract
Current U.S. guidelines recommend integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) as initial treatment for people with HIV (PWH). We assessed long-term effects of INSTI use on lipid profiles in routine HIV care. We analyzed medical record data from the HIV Outpatient Study's participants in care from 2007 to 2021. Hyperlipidemia was defined based on clinical diagnoses, treatments, and laboratory results. We calculated hyperlipidemia incidence rates and rate ratios (RRs) during initial ART and assessed predictors of incident hyperlipidemia by using Poisson regression. Among 349 eligible ART-naïve PWH, 168 were prescribed INSTI-based ART (36 raltegravir (RAL), 51 dolutegravir (DTG), and 81 INSTI-others (elvitegravir and bictegravir)) and 181 non-INSTI-based ART, including 68 protease inhibitor (PI)-based ART. During a median follow-up of 1.4 years, hyperlipidemia rates were 12.8, 22.3, 22.7, 17.4, and 12.6 per 100 person years for RAL-, DTG-, INSTI-others-, non-INSTI-PI-, and non-INSTI-non-PI-based ART, respectively. In multivariable analysis, compared with the RAL group, hyperlipidemia rates were higher in INSTI-others (RR = 2.25; 95% confidence interval (CI): 1.29–3.93) and non-INSTI-PI groups (RR = 1.89; CI: 1.12–3.19) but not statistically higher for the DTG (RR = 1.73; CI: 0.95–3.17) and non-INSTI-non-PI groups (RR = 1.55; CI: 0.92–2.62). Other factors independently associated with hyperlipidemia included older age, non-Hispanic White race/ethnicity, and ART without tenofovir disoproxil fumarate. PWH using RAL-based regimens had lower rates of incident hyperlipidemia than PWH receiving non-INSTI-PI-based ART but had similar rates as those receiving DTG-based ART, supporting federal recommendations for using DTG-based regimens as the initial therapy for ART-naïve PWH. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Driving Automation for Older Adults with Preclinical Alzheimer's Disease.
- Author
-
Ahmadnezhad, Pedram, Burns, Jeffrey M., Akinwuntan, Abiodun E., Ranchet, Maud, Kondyli, Alexandra, Mahnken, Jonathan D., and Devos, Hannes
- Subjects
ALZHEIMER'S disease ,OLDER people ,AUTOMOBILE driving simulators ,OLDER automobile drivers ,AUTOMATION - Abstract
Introduction: Older adults with preclinical Alzheimer's disease (AD) show changes in on-road driving performance. The impact of preclinical AD on using automated vehicle (AV) technology is unknown. The aim was to evaluate safety and cognitive workload while operating AV technology in drivers with preclinical AD. Introduction: This cross-sectional study included 40 participants: 19 older adults (age 74.16 ± 4.78; MOCA scores 26.42 ± 2.52) with preclinical AD, evidenced by elevated cortical beta-amyloid; and 21 controls (age 73.81 ± 5.62; MOCA scores 28.24 ± 1.67). All participants completed two scenarios in a driving simulator. Scenario 1 included conditional automation with an emergency event that required a manual take-over maneuver. Scenario 2 was identical but with a cognitive distractor task. Emergency response time was the main safety outcome measure. Cognitive workload was calculated using moment-to-moment changes in pupillary size and converted into an Index of Cognitive Activity (ICA). Mann-Whitney U and independent t tests were used to compare group differences. Results: Emergency response times were similar between drivers with preclinical AD and controls in scenario 1 (20.85 s ± 1.08 vs. 20.52 s ± 3.18; p = 0.83) and scenario 2 (14.83 s ± 7.37 vs. 13.45 s ± 10.43; p = 0.92). Likewise, no differences were found in ICA between drivers with preclinical AD and controls in scenario 1 (0.34 ± 0.08 vs. 0.33 ± 0.17; p = 0.74) or scenario 2 (0.30 ± 0.07 vs. 0.29 ± 0.17; p = 0.93). Conclusions: Older drivers with preclinical AD may safely operate AV technology, without increased response times or cognitive workload. Future on-road studies with AV technology should confirm these preliminary results in drivers with preclinical AD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation
- Author
-
Aljitawi, Omar S., Paul, Soumen, Ganguly, Avishek, Lin, Tara L., Ganguly, Sid, Vielhauer, George, Capitano, Maegan L., Cantilena, Amy, Lipe, Brea, Mahnken, Jonathan D., Wise, Amanda, Berry, Abigale, Singh, Anurag K., Shune, Leyla, Lominska, Christopher, Abhyankar, Sunil, Allin, Dennis, Laughlin, Mary, McGuirk, Joseph P., and Broxmeyer, Hal E.
- Published
- 2016
- Full Text
- View/download PDF
26. First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function
- Author
-
Myers, Jamie S., primary, Parks, Adam C., additional, Mahnken, Jonathan D., additional, Young, Kate J., additional, Pathak, Harsh B., additional, Puri, Rajni V., additional, Unrein, Amber, additional, Switzer, Phyllis, additional, Abdulateef, Yazan, additional, Sullivan, Samantha, additional, Walker, John F., additional, Streeter, David, additional, and Burns, Jeffrey M., additional
- Published
- 2023
- Full Text
- View/download PDF
27. Simulating and estimating agreement in the presence of multiple raters and covariates
- Author
-
McKenzie, Katelyn A., primary and Mahnken, Jonathan D., additional
- Published
- 2023
- Full Text
- View/download PDF
28. Effect of Cognitive Reserve on Physiological Measures of Cognitive Workload in Older Adults with Cognitive Impairments
- Author
-
Devos, Hannes, primary, Gustafson, Kathleen, additional, Liao, Ke, additional, Ahmadnezhad, Pedram, additional, Kuhlmann, Emily, additional, Estes, Bradley J., additional, Martin, Laura E., additional, Mahnken, Jonathan D., additional, Brooks, William M., additional, and Burns, Jeffrey M., additional
- Published
- 2023
- Full Text
- View/download PDF
29. Broad Therapeutic Time Window for Driving Motor Recovery After TBI Using Activity-Dependent Stimulation
- Author
-
Hudson, Heather M., primary, Guggenmos, David J., additional, Azin, Meysam, additional, Vitale, Nicholas, additional, McKenzie, Katelyn A., additional, Mahnken, Jonathan D., additional, Mohseni, Pedram, additional, and Nudo, Randolph J., additional
- Published
- 2023
- Full Text
- View/download PDF
30. Weight Gain and Metabolic Effects in Persons With HIV Who Switch to ART Regimens Containing Integrase Inhibitors or Tenofovir Alafenamide
- Author
-
Palella, Frank J., primary, Hou, Qingjiang, additional, Li, Jun, additional, Mahnken, Jonathan, additional, Carlson, Kimberly J., additional, Durham, Marcus, additional, Ward, Douglas, additional, Fuhrer, Jack, additional, Tedaldi, Ellen, additional, Novak, Richard, additional, and Buchacz, Kate, additional
- Published
- 2023
- Full Text
- View/download PDF
31. Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin
- Author
-
Morris, Jill K., Vidoni, Eric D., Mahnken, Jonathan D., Montgomery, Robert N., Johnson, David K., Thyfault, John P., and Burns, Jeffrey M.
- Published
- 2016
- Full Text
- View/download PDF
32. Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort
- Author
-
McKenzie, Katelyn A., El Ters, Mirelle, Torres, Vicente E., Harris, Peter C., Chapman, Arlene B., Mrug, Michal, Rahbari-Oskoui, Frederic F., Bae, Kyongtae Ty, Landsittel, Douglas P., Bennett, William M., Yu, Alan S. L., and Mahnken, Jonathan D.
- Published
- 2018
- Full Text
- View/download PDF
33. Longitudinal Changes in P3 Event‐related Potential among Older Adults with Preclinical Alzheimer’s Disease: A 1‐year Follow‐Up
- Author
-
Estes, Bradley J, primary, Gustafson, Kathleen, additional, Liao, Ke, additional, Martin, Laura E, additional, Ahmadnezhad, Pedram, additional, Kuhlmann, Emily, additional, Brooks, William M, additional, Mahnken, Jonathan D, additional, Burns, Jeffrey M., additional, and Devos, Hannes, additional
- Published
- 2022
- Full Text
- View/download PDF
34. Effect of cognitive reserve on physiological measures of cognitive workload in older adults with cognitive impairments
- Author
-
Devos, Hannes, primary, Gustafson, Kathleen, additional, Liao, Ke, additional, Ahmadnezhad, Pedram, additional, Kuhlmann, Emily, additional, Estes, Bradley, additional, Martin, Laura E., additional, Mahnken, Jonathan D., additional, Brooks, William M., additional, and Burns, Jeffrey M., additional
- Published
- 2022
- Full Text
- View/download PDF
35. The physical frailty phenotype: Not ready for implementation
- Author
-
Gupta, Aditi, primary, Mahnken, Jonathan D., additional, and Cibrik, Diane M., additional
- Published
- 2022
- Full Text
- View/download PDF
36. Implementing a home-based virtual hypertension programme—a pilot feasibility study
- Author
-
Gupta, Aditi, primary, Ellis, Shellie D, additional, Burkhardt, Crystal, additional, Young, Kate, additional, Mazzotti, Diego R, additional, Mahnken, Jonathan, additional, Abu-el-rub, Noor, additional, Chandaka, Sravani, additional, Comfort, Branden, additional, Shanks, Denton, additional, Woodward, Jennifer, additional, Unrein, Amber, additional, Anderson, Heidi, additional, Loucks, Jennifer, additional, Song, Xing, additional, Waitman, Lemuel R, additional, and Burns, Jeffrey M, additional
- Published
- 2022
- Full Text
- View/download PDF
37. Dementia risk and dynamic response to exercise: A non-randomized clinical trial
- Author
-
Vidoni, Eric D., primary, Morris, Jill K., additional, Palmer, Jacqueline A., additional, Li, Yanming, additional, White, Dreu, additional, Kueck, Paul J., additional, John, Casey S., additional, Honea, Robyn A., additional, Lepping, Rebecca J., additional, Lee, Phil, additional, Mahnken, Jonathan D., additional, Martin, Laura E., additional, and Billinger, Sandra A., additional
- Published
- 2022
- Full Text
- View/download PDF
38. COMbined Exercise Trial (COMET) to improve cognition in older adults: Rationale and methods
- Author
-
Szabo-Reed, Amanda, primary, Clutton, Jonathan, additional, White, Sydney, additional, Van Sciver, Angela, additional, White, Dreu, additional, Morris, Jill, additional, Martin, Laura, additional, Lepping, Rebecca, additional, Shaw, Ashley, additional, Puchalt, Jaime Perales, additional, Montgomery, Robert, additional, Mahnken, Jonathan, additional, Washburn, Richard, additional, Burns, Jeffrey, additional, and Vidoni, Eric D., additional
- Published
- 2022
- Full Text
- View/download PDF
39. Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34+ cells in a murine model of umbilical cord blood transplantation
- Author
-
Aljitawi, Omar S., Xiao, Yinghua, Eskew, Jeff D., Parelkar, Nikhil K., Swink, Megan, Radel, Jeff, Lin, Tara L., Kimler, Bruce F., Mahnken, Jonathan D., McGuirk, Joseph P., Broxmeyer, Hal E., and Vielhauer, George
- Published
- 2014
- Full Text
- View/download PDF
40. Derivation and validation of a formula to estimate risk for 30-day readmission in medical patients
- Author
-
TAHA, MOHAMMAD, PAL, AROOP, MAHNKEN, JONATHAN D., and RIGLER, SALLY K.
- Published
- 2014
41. Restoration of function after brain damage using a neural prosthesis
- Author
-
Guggenmos, David J., Azin, Meysam, Barbay, Scott, Mahnken, Jonathan D., Dunham, Caleb, Mohseni, Pedram, and Nudo, Randolph J.
- Published
- 2013
42. Implementing a home-based virtual hypertension programme—a pilot feasibility study.
- Author
-
Gupta, Aditi, Ellis, Shellie D, Burkhardt, Crystal, Young, Kate, Mazzotti, Diego R, Mahnken, Jonathan, Abu-el-rub, Noor, Chandaka, Sravani, Comfort, Branden, Shanks, Denton, Woodward, Jennifer, Unrein, Amber, Anderson, Heidi, Loucks, Jennifer, Song, Xing, Waitman, Lemuel R, and Burns, Jeffrey M
- Subjects
PHARMACISTS' attitudes ,BLOOD pressure ,FEASIBILITY studies ,PILOT projects ,HYPERTENSION - Abstract
Introduction Implementing a health system-based hypertension programme may lower blood pressure (BP). Methods We performed a randomized, controlled pilot study to assess feasibility, acceptability, and safety of a home-based virtual hypertension programme integrating evidence-based strategies to overcome current barriers to BP control. Trained clinical pharmacists staffed the virtual collaborative care clinic (vCCC) to remotely manage hypertension using a BP dashboard and phone "visits" to monitor BP, adherence, side effects of medications, and prescribe anti-hypertensives. Patients with uncontrolled hypertension were identified via electronic health records. Enrolled patients were randomized to either vCCC or usual care for 3 months. We assessed patients' home BP monitoring behaviour, and patients', physicians', and pharmacists' perspectives on feasibility and acceptability of individual programme components. Results Thirty-one patients (vCCC = 17, usual care = 14) from six physician clinics completed the pilot study. After 3 months, average BP decreased in the vCCC arm (P = 0.01), but not in the control arm (P = 0.45). The vCCC participants measured BP more (9.9 vs. 1.2 per week, P < 0.001). There were no intervention-related adverse events. Participating physicians (n = 6), pharmacists (n = 5), and patients (n = 31) rated all programme components with average scores of >4.0, a pre-specified benchmark. Nine adaptations in vCCC design and delivery were made based on potential barriers to implementing the programme and suggestions. Conclusion A home-based virtual hypertension programme using team-based care, technology, and a logical integration of evidence-based strategies is safe, acceptable, and feasible to intended users. These pilot data support studies to assess the effectiveness of this programme at a larger scale. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
43. A heavy burden: preexisting physical and psychiatric comorbidities, and differential increases among male and female participants after initiating antiretroviral therapy in the HIV Outpatient Study, 2008-2018.
- Author
-
Tedaldi, Ellen M, primary, Armon, Carl, additional, Li, Jun, additional, Mahnken, Jonathan, additional, Simoncini, Gina, additional, Palella, Frank J., additional, Carlson, Kimberly, additional, and Buchacz, Kate, additional
- Published
- 2022
- Full Text
- View/download PDF
44. Atrial fibrillation and risk of stroke in dialysis patients
- Author
-
Wetmore, James B., Ellerbeck, Edward F., Mahnken, Jonathan D., Phadnis, Milind, Rigler, Sally K., Mukhopadhyay, Purna, Spertus, John A., Zhou, Xinhua, Hou, Qingjiang, and Shireman, Theresa I.
- Published
- 2013
- Full Text
- View/download PDF
45. Additional file 1 of EEG/ERP evidence of possible hyperexcitability in older adults with elevated beta-amyloid
- Author
-
Devos, Hannes, Gustafson, Kathleen, Liao, Ke, Ahmadnezhad, Pedram, Estes, Bradley, Martin, Laura E., Mahnken, Jonathan D., Brooks, William M., and Burns, Jeffrey M.
- Abstract
Additional file 1: Table S1. P3 peak amplitude and latency at Fz/Cz/Pz across testing conditions of CNA��+ and CNA�����. Table S2. Event-related power (��V/Hz2) at Fz/Cz/Pz, across testing conditions of CNA��+ and CNA����� (Mean �� SD). Table S3. Event-related power (��V/Hz2) of CNA��+ (n = 17) and CNA����� (n = 17) at Fz/Cz/Pz, across testing conditions (Mean �� SD).
- Published
- 2022
- Full Text
- View/download PDF
46. Dementia Risk and Dynamic Response to Exercise: A non-randomized clinical trial
- Author
-
Vidoni, Eric D, primary, Morris, Jill K, additional, Palmer, Jacqueline A, additional, Li, Yanming, additional, White, Dreu, additional, Kueck, Paul J, additional, John, Casey S, additional, Honea, Robyn A, additional, Lepping, Rebecca J, additional, Lee, Phil, additional, Mahnken, Jonathan, additional, Martin, Laura E, additional, and Billinger, Sandra A, additional
- Published
- 2022
- Full Text
- View/download PDF
47. The Changing Health and Social Circumstances of Women Leaving Jails: A Three-Year Longitudinal Study
- Author
-
Allsworth, Jenifer, Assimonye, Stephanie, Lee, Jaehoon, Smith, Sharla, Glenn, Jason, Ramaswamy, Megha, Mosier, Brian, Bantis, Leonidas, Elsarraj, Hanan, Kafuman, Carolyn, Limback, Darlene, Hong, Yan, Harper, Haleigh, Ricci, Lawrence R., Fan, Fang, Tawfik, Ossama, May, Lisa, Cusick, Therese, Inciardi, Marc, Redick, Mark, Gatewood, Jason, Winblad, Onalisa, Fields, Tim, Fabian, Carol, Godwin, Andrew K., Fields, Patrick E., Meierotto, Ruby, Li, Linheng, Perry, John, Behbod, Fariba, Bengston, Charles, Bloomer, Clark, Sharma, Palash, Mahnken, Jonathan, Hui, Dongwei, Michaelis, Mary, Michaelis, Elias, Swerdlow, Russell, Chalise, Prabhakar, Dallas, Sarah, Dandawate, Prasad, Perko, Victoria, Forbush, Kelsie, Gould, Sara, Richson, Brianne, Christian, Kylie, Chapa, Danielle, Martin, Laura, Johnson, Mark, Carpenter, Matthew J., Smith, Tracy T., Nollen, Nikki, Leavens, Eleanor, Lewis, Charley, Lin, Tara L., Perry, John M., He, Xi, Reed, Gregory, Zhang, Na, Weir, Scott, McGuirk, Joseph P., Lumpkins, Crystal Y., Goeckner, Ryan, Hale, Jason, Gunville, Jordyn, Gunville, River, Daley, Chris M., Philp, Alisdair, Kimminau, Kim, Ramirez–Mantilla, Mariana, Mustafa, Reem, Godwin, Andrew, Vazquez, Yani, Washington, Nancy, Jones, Kim, Freeman, Shaton, Martin, Laura E., Brucks, Morgan G., Fox, Andrew, Papa, Vlad B., Mdege, Noreen D., Baldwin, Austin S., Trucco, Elisa M., Cooperman, Nina A., Kassianos, Angelos P., Levens, Sara M., Onianwa, Ebony, Petersen, Shariska, Pleskac, Timothy J., Grunevski, Sergej, Liu, Taosheng, Cesario, Joseph, Rosa-Molinar, Eduardo, Shafer, Robin L., Wang, Zheng, Mosconi, Matthew W., Berkley-Patton, Jannette, Wickliffe, Joi, Springer, Jason, Funk, Ryan, Statland, Jeffrey, Sullivan, Debra, Szabo-Reed, Amanda, Wambach, Karen, Cojocari, Chelsea, Frazier, Rachel, Halpin, Kelsee, Toren, Paul, Leeder, J. Steven, Yan, Yun, Ghosh, Priyanka, He, Lin, Magee, Nancy, Ahamed, Forkan, Wu, Xiaoqing, Xu, Liang, and Zhang, Yuxia
- Subjects
Frontiers Research Day Abstracts - Abstract
Introduction The past two decades have seen a revolution in the management of labor and delivery; rates of cesarean delivery (CD), medical induction, and electronic fetal monitoring have increased dramatically. CD occurs in one third of deliveries and is the most common inpatient surgery. The increase in CD has occurred despite concerns about maternal complications (infection, blood loss, hysterectomy, uterine rupture) and racial disparities. Since 1993, black and white women have gone from comparable CD rates to rates 40% higher among black women compared to white women. Methods This project has assembled a cohort of over 800,000 deliveries from the Cerner Corporation’s Health Facts® database. Health Facts contains 63 million unique patients from over 600 U.S. healthcare facilities. Data include comprehensive clinical records from inpatient and outpatient encounters and includes data from pharmacy, laboratory, registration and billing data. Results CD was identified using a validated definition that incorporates International Classification of Disease (Version 9, Clinical Modification) codes for delivery outcome and relevant diagnosis-related groups and procedures. We examined 618,582 singleton deliveries to black and white women and identified 177,564 cesarean deliveries (28.7%). Conclusions The rate of cesarean was higher for black women overall and during the years 2000 – 2006 and 2011 – 2015 the CD rate for black women was significantly higher than for white women. Of note, during the period from 2007 – 2010 rates of cesarean were similar among black and white women. The rate of repeat cesarean was lower among black women, while the rate of induction of labor was higher., Introduction Ninety-five percent of all inmates are eventually released back into communities, with many being released without access to the most basic of necessities. Women in particular face complex health and social challenges – children, partners, strained employment opportunities, health problems – before incarceration that they must also face upon reentry. This poses a barrier to their successful reintegration back into society. Methods The present study analyzes data collected as part of the sexual health empowerment (SHE Project) health literacy intervention. Participants were recruited from three county jails in the greater Kansas City area. At baseline, participants completed a survey that assessed sociodemographic characteristics and social histories prior to incarceration. Women were followed annually after program completion to complete surveys to assess their long-term health and social circumstances. The present study is a secondary analysis of baseline and follow-up data. Anticipated Results We use Hobfoll’s Conservation of Resources (COR) Theory to conceptualize the stress that justice-involved women may experience as a result of perceived or actual loss of resources. We hypothesize that “loss spirals”, a term coined by Stevan Hobfoll, creates psychological stress that drives justice-involved women to assume risky sex and drug behaviors that will generate more resources and help to cope with the stress. Significance of Impact This study aims to define a succinct longitudinal timeline assessing biopsychosocial outcomes of women released from jail in order to improve prevention and intervention techniques for improvement in social and health circumstances of women leaving jail and their reduction in recidivism., Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal forms of cancer with a five-year survival rate ~7%. Thus, early detection could be key to reducing its mortality. Finding effective biomarkers is crucial to early detection. Pancreatic cancer biomarker studies typically consider more than two classes (i.e., recruited individuals that are either healthy, suffering from pancreatitis/cysts, or from aggressive PDAC). Conventional ROC curve analysis is the most popular tool to assess the discriminatory ability of biomarkers in distinguishing between two groups. For more than two groups, this approach is inadequate to determine decision cutoffs for decision-making purposes. Currently there is no accuracy-based statistical approach that is immune to the prevalence of the disease and is able to accommodate information from all three groups to optimally determine a decision rule for classification of patients. We propose a Euclidian distance-based approach as a method of estimating optimal cutoff values. We provide a full analysis framework when interest lies in decision-making and provide parametric and nonparametric approaches. Our approaches can easily be generalized into k-class problems when we are interested in distinguishing between four or more classes. We can extend our methods to consider the costs of incorrect decision making for each of the groups and weigh them accordingly. Additionally, combinations of biomarkers or relevant clinical information can also be accommodated straightforwardly to improve decision rules. We illustrate the usefulness of our approaches by analyzing a pancreatic cancer biomarker study conducted at the University of Texas MD Anderson Cancer Center., Introduction To study breast cancer progression, we developed the Mouse-Intraductal (MIND) model which involves intraductal injection of breast cancer cells into the mammary ducts of immunocompromised mice, where they display a course remarkably similar to the evolution of human breast cancer, with the formation of lesions in situ followed by invasion into the surrounding stroma. More recently, we are collecting peripheral blood from these same women and have been successful in humanizing mice with the patient’s own hematopoietic stem cells (HSC). Preliminary Data We have achieved successful engraftment of peripheral blood-derived and bone marrow-derived human CD34+ cells into NSG (immunodeficient NOD-SCID Il2rg−/−), MISTRG (immunodeficient Rag2−/−Il2rg−/− transgene SIRPa expressing GM-CSF, IL-3, M-CSF, TPO) and MISTRG6 mice (plus IL-6) and observed recruitment of their progenitors to breast cancer lesions. Our preliminary studies demonstrate preferential myeloid development when using peripheral blood derived CD34+ cells, while both myeloid and lymphoid development are achieved when using bone marrow derived CD34+ cells. Furthermore, MISTRG6 mice show improved development of both human myeloid and lymphoid hematopoietic cells compared to MISTRG and NSG mice. Impact and Future Aims The major advantage of our model is the ability to observe progression of patient breast cancer and their associated immune cells in vivo. Analyzing patient samples eliminates the ability to track the progression of lesions and their associated immune cells in vivo. By maximizing these unique advantages, we hope our results will help guide individualized immunotherapy in future patient care., Introduction Although causal linkage between hyperglycemia and decreased lung function in cystic fibrosis (CF) is unknown, it is thought to be related to excess inflammation and ion channel dysfunction. Methods We utilized complementary in vitro and in vivo approaches to assess the effects of hyperglycemia on the CF airway epithelium. In vitro: Primary CF bronchial epithelial (CFBE) cells at the air-liquid interface under hyperglycemic (HG; 255 mg/dL) or normoglycemic (NG; 100 mg/dL) conditions. Airway surface liquid (ASL) was measured by meniscus scanning and apical K+ (BK) ion channel current was measured in Ussing chambers. In vivo: In CF subjects with or without CF related diabetes (CFRD), glycemic control was measured using continuous glucose monitoring. Results Nasal epithelial cells were collected and analyzed by qPCR for the expression of RAGE, TGF-1, and LRRC26, the regulatory subunit of BK. Compared to normoglycemia, CFBE cells under hyperglycemia show significantly reduced ASL (68.4 ± 17.4 μL, NG vs. 51.5 ± 18.1 μL, HG; p, The University of Kansas Medical Center – Genomics Core leveraged the Frontiers: KU Clinical and Translational Science Institute infrastructure award to purchase an Eppendorf MasterCycler Pro thermal cycler and Countess II Automated Cell Counter to support the single cell initiative of the Genomics Core at KUMC. The MasterCycler Pro and Countess II are used to support the 10X Genomics Chromium Controller for performing the full suite of 10X Genomics single cell applications which include Single Cell 3′ Gene Expression, Single Cell 5′ Expression and V(D)J Enrichment and Single Cell ATAC – Chromatin Profiling. The Countess II Automated Cell Counter is used to ensure that adequate cell counts and high viability of submitted samples are present. The Countess also allows visualization of any cellular debris or cell clumping which will interfere with a successful 10X emulsification procedure required for a successful single cell library preparation. The MasterCycler Pro has been sequestered to exclusively support single cell library preparations. The MasterCycler performs the initial single strand synthesis which incorporates the 10X GEM barcode and Unique Molecular Identifier (UMI), second strand synthesis and Illumina adapter ligation to complete the 10X library preparation. These instruments have proven critical to the successful execution of 16 single cell projects in support of seven different investigators. Frontiers’ investment in the single cell initiative has had a positive impact on cutting edge single cell expression and epigenetic research performed at the University of Kansas Medical Center., Introduction Alzheimer’s disease (AD) is the most common form of irreversible, progressive dementia that affects memory loss, cognitive capabilities, and behavior. Although, significant progress has been made to understand genetic and clinical risk factors associated with AD, our understanding of AD remains incomplete resulting in ineffective prevention or cure. Methods Several studies have indicated that the polymorphisms in the mitochondrial DNA (mtDNA) play an important role in the mechanism of AD. Therefore, in order to understand the association of the mitochondrial genetic alteration with AD, we carried out cross-sectional association analysis using the clinical and mitochondrial single nucleotide polymorphism (SNP) data. We used the data collected at University of Kansas Alzheimer’s Disease Center (KU ADC) to carry out the analyses. We also used the data from Alzheimer’s Disease Neuroimaging Initiative (ADNI) for the replication and validation analyses. Results The KU ADC data consists of 146 AD and 265 cognitively normal subjects, and ADNI data has 244 AD and 242 controls. For both datasets, the haplogroups information for each subject and APOE ɛ4 carrier status were also available. Conclusions We found that the rates of incidence of AD were statistically significantly different among the haplogroups, with differing strengths of association for different haplogroups. APOE ɛ4 was significantly associated with AD overall (p-value = 1.9×10–11) and the association varied by haplogroups (i.e., interaction). The results were consistent with the ADNI data. Our study has generated hypothesis and the data for further studies ahead to understand the etiology of AD., Introduction Age-related bone loss and associated fracture risk is an increasing concern worldwide. Oxidative stress causes mitochondrial damage and is associated with age-related degeneration in many cell systems, including bone cells. Methods To understand mitochondrial function in bone cells in situ, live-cell and intravital imaging of mitochondrial NADH and mitochondrial morphology was performed using transgenic mice expressing GFP in osteocytes as well as in MLO-Y4 osteocyte-like cells and OmGFP66 cells, which model osteoblast-to-osteocyte transition. NADH excitation and emission spectra in live osteocytes and osteoblasts matched well with pure NADH, with maximal multiphoton excitation at 740 – 760nm, resulting in blue NADH autofluorescence. With 760nm excitation, maximal NADH emission occurred at 460nm. Metabolic challenge was performed with carbonylcyanide-3-chlorophenylhydrazone and sodium cyanide, which convert NADH to its maximally oxidized or reduced states. Results This showed that osteoblasts had a lower resting redox state, with 40% of their NADH in a reduced state, compared to osteocytes with 75 – 80%. Live imaging using mitotracker Red-CMXRos showed that osteocytes have fewer mitochondria, lower mitochondrial area and % area, and increased solidity. Conclusions These data show that osteocytes in vivo under normoxic conditions have significant levels of mitochondrial NADH and show differences in mitochondrial number, morphology and function compared to osteoblasts. These live-cell imaging techniques can be used to determine changes in mitochondrial function during aging/cellular senescence and disease. These studies were supported by Frontiers equipment funding, including a Tokai-Hit CO2 incubation system, Leica 16× and 20× objectives and Imaris9.2 software which are available to other investigators through the UMKC Confocal Imaging Core., Introduction Pancreatic cancer (PDAC) is the fourth leading cause of cancer-related deaths in the U.S. Gemcitabine remains the drug of choice for metastatic disease, but only little improvement is seen in survival rates. Hence, there is a dire need for novel therapeutics for PDAC. We found that PRLR is overexpressed in PDAC tissues and cell lines and knockdown of the receptor resulted in reduced tumor formation in mice. Hence, PRLR is a novel target for therapeutic interventions in PDAC. Methods As there is no small molecular inhibitor available for targeting the receptor, we developed a homology model of the intracellular domain of PRLR that encodes the JAK2 binding site, and then performed a virtual screening of small molecules using IDOCK and I-TASSER servers. Using Fragment-based drug design, we derived commercially available compounds for virtual screening. We selected several compounds that came out of the virtual screening and performed in vitro proliferation assays in the PDAC cells. We identified antipsychotic drugs including penfluridol that can inhibit the proliferation of PDAC cell lines. Moreover, pretreatment of these antipsychotic drugs inhibited PRL-induced STAT3 and ERK phosphorylation in PDAC cell lines. Further, we used cellular thermal shift assay and drug affinity binding assay to confirm the binding of Penfluridol and PRLR. We also used cell-free systems such as surface plasmon resonance (SPR) and magnetic relaxometry to confirm the drug binding. Moreover, Penfluridol treatment significantly decreased pancreatic tumor burden in animal models. In conclusion, we identified penfluridol is a potential drug candidate for targeting PRLR in PDAC., Introduction Anorexia nervosa (AN) is a serious condition associated with numerous medical complications, psychiatric comorbidity, and the highest mortality rate of any psychiatric disorder. Relapse rates remain high and for many, AN becomes an enduring condition. The only reliable prognostic indicator for AN is “rapid response” (i.e., weight gain over the first four weeks of treatment). Yet, there are no reliable predictors of rapid response at baseline. There is a pressing need to identify novel neuro-markers that confer early risk for poor treatment outcome. Methods Study goals were to systematically identify potential neuro-markers related to short-term AN outcomes by assessing brain activation associated with delayed discounting (capacity to delay immediate gratification), sensitivity to food reward (responses to rewarding foods and decisions to choose palatable foods), and threat sensitivity (heightened reactivity to potential danger or harm). The purpose of this study was to identify neural predictors of short-term treatment response in adolescents with AN. Participants were adolescent females with AN who entered their first course of eating-disorder treatment within the past six months. Specific aims 1) Test neural activation during tasks measuring delayed discounting, food reinforcement, and threat and 2) Identify prospective associations of task-performance and task-based neural activation with eating-disorder symptoms at one-month follow-up. Conclusions Differentiating neurobiological processes that contribute to AN chronicity may lead to the development of prognostic indicators at initial treatment presentation. These neuromarkers may improve clinical decision-making and allow providers to identify patients requiring more intensive treatment interventions to prevent chronicity and mortality., Introduction Osteocytes are the primary mechanosensory cell in bone and activate β-catenin signaling in response to mechanical loading of bone. Methods In order to understand the mechanism by which osteocytes activate β-catenin signaling, we have developed a stably transfected osteocyte cell line that expresses luciferase when β-catenin signaling occurs in the nucleus. To quantitate luciferase activity, we purchased a VICTOR Nivo Multimode Plate Reader (Perkin-Elmer) with the support of Frontiers funding. This instrument quantitatively measures luciferase activity (fluorescence and absorbance) in several plate formats, thus permitting high throughput screening of compounds that activate β-catenin signaling. We stably transfected the MLO-Y4 osteocyte-like cell line with the TOPflash vector pGL4.9[luc2P/TCF_LEFRE/Hygro] (Promega). Clone A3–F9 gave a dose response to increasing concentrations of Wnt3a (1–100ng/ml) and activation with 10mM LiCl gave the equivalent of a submaximal dose of Wnt3a (10ng/ml). Results We demonstrated that C2C12 myotubes, but not myoblasts, produce a factor that activates β-catenin signaling two-fold using these TOPflash-MLO-Y4 cells, but in combination with Wnt3a (10 ng/ml; 10-fold activation) produces a 20–30-fold increase in activity measured in our luciferase assay. We demonstrated that production of this factor by C2C12 myotubes is partially regulated by mTOR signaling. We are currently seeking to identify this factor using our TOPflash-MLO-Y4 cells. Conclusions The acquisition of the VICTOR Nivo Multiplate reader provides us the means to conduct a high throughput screening approach to identify this factor(s). This instrument is part of a Core in the UMKC School of Dentistry Department of Oral and Craniofacial Sciences and available to other investigators for their studies., Introduction Initiation of JUUL use by young adults is one of the most significant issues of concern within the debate on vaping. Despite the proliferation of products and the surge in prevalence, no studies have investigated individual-level interventions or prevention strategies for pod-mod use. Methods Participants (N = 947) were young adults (< 30 years old) recruited from Amazon’s Mechanical Turk based on smoking (never, former, and current smokers) and JUUL use status (never and current users). In a pre-post design, participants completed baseline assessments, were presented with a brief JUUL-specific educational intervention and completed post-assessment measures. Primary outcomes were changes in JUUL knowledge, perceived harmfulness, intentions for future use, and motivation to change. Results Participants (Mean age = 26.1) were male (57%) and White (75%). Overall, the intervention increased JUUL-related knowledge, risk perceptions, commitment to quitting, and readiness to quit JUUL (all p ≤ 0.001). Similarly, participants showed decreased interest in future JUUL use, interest in purchasing JUUL, and interest in future regular JUUL use (all p ≤ 0.001). There were significant Time X Group interactions for JUUL-related knowledge (p < 0.001), with never JUUL/never smokers showing the greatest increase in product knowledge following the intervention. However, no other interaction effects were significant. Discussion The intervention was effective in increasing knowledge and risk perceptions while reducing intentions for future use. The intervention was most effective in increasing knowledge among non-users, suggesting that brief educational interventions may be useful tools for preventing pod-mod initiation while more intensive interventions may be necessary to alter attitudes and use behaviors among current users., Introduction American Indians (AI) have the highest rates of smoking and smokeless tobacco (SLT) use among all major racial/ethnic groups. There is limited information about the use of alternative tobacco (AT) products such as electronic cigarettes. The objective of this pilot study is to understand the knowledge, attitudes, beliefs, and behaviors (KABB) surrounding AT product use among AI college students. Methods We conducted 19 focus groups with AI college students age 18 and older. Participants were stratified by AT use, cigarette use, and never users of tobacco products. Focus groups were audio-recorded and transcribed verbatim in preparation for coding and standard text analysis. Participants completed a short survey that collected information on demographics and KABB about tobacco products. Surveys were analyzed with frequencies and measures of central tendencies. Results Participants included 105 AI college students. Participant’s mean age was 21 years and 50% were female. Focus groups ranged in size from two to nine. Related to e-cigarette use, participants cited flavors, discreteness, stress, and social aspects as factors for use. Survey results indicate that 35% of participants were current e-cigarette users, 30% were current smokers, and 9% were current SLT users. Conclusion This pilot study confirms that AI college students are following a similar trend to other racial/ethnic groups in terms of AT use. It is important that we obtain estimates of AT use and include AI in prevention and cessation efforts. This study will help develop appropriate prevention and cessation messaging for this population., Introduction A proof of concept trial (NCT02914977) was designed to measure the ability of low dose DNR to inhibit pS552-β-catenin in LSCs of adult relapsed/refractory AML patients. A protocol amendment added a second cohort of patients with newly diagnosed AML undergoing standard chemotherapy with DNR and cytarabine (7+3 induction). Methods Treatment in each cohort consisted of DNR given at a dose of 6.75mg/m2/day × five days. Patients with relapsed/refractory AML had bone marrow aspiration pre-treatment prior to day 1, followed by DNR on days 1–5, and a post-treatment bone marrow aspiration on day 8. Patients with newly diagnosed AML were treated with conventional 7+3 chemotherapy. Results A sample from the day 14 bone marrow was collected. DNR was given on days 15 – 19. Bone marrow aspiration was performed with blood count recovery and samples sent for LSC marker assessment. Discussion In this study, we will determine the safety, pharmacokinetics, and pharmacodynamic effects of low dose DNR. The LSC population and phosphorylation status of β-catenin will be measured pre-and post-treatment. Two or more prior induction attempts are required for study entry for refractory patients; relapsed patients require only one prior induction. The trial completed its accrual goal of 18 patients. Low-dose DNR treatment was well-tolerated with no unexpected adverse events. In this pilot proof of concept trial, we will demonstrate the feasibility of serial bone marrow aspiration to measure biomarkers of LSC response., Introduction American Indians (AI) are disproportionately and significantly impacted by disease morbidity, mortality and poor behavioral health outcomes. Based on data from the National Vital Statistics Reports, the leading cause of death among AI is cancer (19%), followed by heart disease (18%). Regionally, health disparities among AIs reflect national statistics. Health communication targeted to address these health disparities exist; however, few evidence-based strategies integrate holistic approaches. The impact of health communication research and practice is evolving and continues to emerge as a core part of health promotion. Strategies that appeal and increase persuasiveness of health messages are more likely to penetrate existing cultural beliefs and positively influence health behavior outcomes. The objective of this study was to explore how tribal and elder leaders throughout the Plains viewed themselves as health communicators within their communities. Methods Members of the Center for American Indian Community Health conducted 39 in-depth interviews from December 2017 to December 2018 with members of federally recognized tribes living in reservation communities, as well as urban tribal communities across the region. Results Results from this sample show that these individuals do not see themselves as the “authority” health communicator within their tribe and community. The term health promoter was viewed as problematic in Native communities for cultural reasons. Conclusion Overarching themes included seeing themselves as communicators of holistic health, specific health prevention programs, access, targeted communication and health promoters as a collective unit. Collective social and cultural authority in tailored messages is perceived to bolster health communication and positively impact health outcome., Introduction Minority and underserved populations carry the largest cancer burden for the United States (ACS, 2016). Genetic counseling, testing and technologies show promise to help reduce cancer through personalized medicine opportunities however disproportions of genetic services, uptake and research about genetic testing among these populations exist (Ricker, et al., 2018). Inequitable cancer-related genetic and genomic testing (CGT) communication among minority and underserved populations and other barriers (e.g., genetic counselor bias) may contribute to CGT disparities. Exploring existing attitudes, perceptions and beliefs toward CGT among minority and underserved patient populations may bolster strategies to address communication inequities. The study aims were to explore an under-researched area of precision medicine, i.e., the communication of genetic risk factors among minority and underserved patient populations with high to moderate risk and disseminate and share findings with the community. Methods A Community Advisory Board comprised of researchers, cancer survivors and family members of cancer patients met from December 2018 – March 2019 to discuss research design and data collection. Six stratified focus group discussions (N = 53) were held March – May 2019 where a pre-focus group survey was administered. Results Survey results show most had not talked to their doctor/health care provider about genetic testing (87%). African Americans (AA) and Latinos expressed a lack of awareness and knowledge about CGT and the importance of cultural tailoring. Conclusion Separate themes that emerged among Latinos included immigration status and language as barriers to CGT. Among AA, participants were highly distrustful of medical personnel and expressed outrage about the lack of recommendation for CGT., Introduction Engaging in healthy behaviors is not always rewarding (e.g., carrot vs. cake). Neural models of healthy behaviors focus on the balance between reward and regulation brain regions. This pilot study examines the engagement of reward and regulation regions during the evaluation of food and nonfood cues before and after a guided imagery exercise targeting positive associations with food and regulation. Our long-term goal is to understand the interaction between positive associations with healthy foods and thinking about future rewards may influence healthy decision-making. The objective of the current study is to empirically test the combined effects of positive affect and positive episodic future thinking on brain activation. Methods The project examined the effect of positive affect and episodic future thinking guided imagery on brain activation in regulation and reward regions. Participants included individuals with a body mass index greater than 25 (n = 20). Results Functional neuroimaging showed reduced activation in regulation-related brain regions (i.e., dorsomedial prefrontal cortex) to healthy and unhealthy food following guided imagery. Conclusions These results suggest more efficient regulation-related brain activation after positive episodic future thinking guided imagery., Introduction The Establishing Meaningful Patient-centered Outcomes With Relevance for patients with Polycystic Kidney Disease (EMPOWER PKD) initiative aims to engage PKD stakeholders and patients to learn about health priorities, insurance issues, and patient engagement. Methods We utilized semi-structured focus groups. We developed and pre-piloted a guide that allowed for both conversational flow and consistency in questions among groups. We audio-recorded each group and transcribed the conversations verbatim. We performed an inductive thematic analysis. Two investigators completed all data coding independently and in duplicate. We compare the results of an ethnically diverse focus group to the other seven that mainly included Caucasian participants. Results 14 individuals participated in this part of the study. Of these, (64.2%) reported having PKD, and (14.2%) being caregivers. The mean age of participants was 48.8 (range 29 – 75) years. The group included 85.75% African American and 7.1% reported more than one race. Conclusions It was challenging to recruit this group and it required establishing a relation with community nephrologists and faith-based organizations leads. Multiple participants stated that they would not have participated if the group was not exclusively ethnically diverse as they fear that their opinion may be outnumbered by a Caucasian majority. Some discussed believing that PKD was a “white” disease. Many discussed hiding their diagnosis which affected their activation and engagement and came with unanticipated psychological impacts. Participants unanimously described lack of trust-worthy, easy to understand educational resources for minorities as a main barrier to engagement., Introduction The highest rates of obesity in the U.S. are among black women with a prevalence of 54.8%. Psychosocial factors, such as stress from racism, have been proposed as contributors to this disparity, but the mechanisms are unclear. The objective of this study is to understand the relationship between race-related stress and food choice among black women. Methods Forty-five participants were asked to come in fasted for two appointments, randomized to the order of stress exposure in a within subject design. Forty images for each condition were collected from two validated picture sets (International Affective Picture set and Socio Moral Image Database). The images were shown in random order and contained either racially charged scenes (e.g., Ku Klux Klan) or non-racially charged scenes (e.g., aggressive dog) matched on valence (pleasant vs. unpleasant) and arousal (physiologically stimulating). Food choice and food demand tasks were completed pre and post stress exposure. Participants were surveyed on their stress levels, past experiences of racism, and trauma. Anticipated Results It is expected that preferences for unhealthy foods will be greater after race related stress exposure compared to the other stress condition. We anticipate that those who have higher BMI’s are more likely to be affected in their changes in eating behaviors in both stress exposure states, with a larger impact from the race related stress induction. Data collection is ongoing., Introdution To examine the impact of residential distance and socioeconomic status on survival outcomes for patients receiving treatment for ovarian cancer at an NCI-CC. Methods Patients who were treated for ovarian cancer at a single institution from 2010 – 2015 were identified. Age at diagnosis, insurance status, and distance from the patient’s home to the institution were abstracted. Clinical data including stage at diagnosis, surgical status, chemotherapy cycles, dates of diagnosis, recurrence, and death were obtained. Patients treated at other institutions and those with non-epithelial pathology were excluded. Patients were stratified into three groups based on distance from the institution. Overall survival (OS) and progression free survival (PFS) were generated by Kaplan Meier survival curves and Cox proportional hazard models using SAS v9.4. Results Two hundred and three patients were identified. Survival analysis based on distance demonstrated that patients who lived less than 10 miles from the institution have worse survival (p = 0.0412). Lower median income (< 56,179) regardless of distance to institution was also associated with worse survival, p = 0.0283. After adjusting for stage of disease, age at diagnosis, surgery status, chemotherapy resistance, income quartile and presence of comorbid conditions, distance < 10 miles from the institution was still a significant predictor of worse overall survival, HR 2.62 95% CI (1.333 – 5.142), p = 0.0052. Conclusion Among patients who received guideline-adherent care for ovarian cancer, lower median income and residential distance less than 10 miles to an NCI-CC was associated with worse overall survival., Introduction The shooting of unarmed citizens by police officers is a topic at the forefront of public awareness. The disproportionate rate at which unarmed Black citizens are shot is believed to reflect widespread racial bias on behalf of officers, which erodes public trust and reduces policing effectiveness. Methods We have developed an Attention-integrated Model-based Shooting Simulator (AiMSS) to gain a deeper understanding of the mechanisms underlying the decision to shoot. The AiMSS combines computational models of decision making, visual psychophysics and eye-tracking methods, and an immersive decision simulator to map the processes police officers use to decide to shoot. Results Results with the AiMSS reveal that policing scenario and suspect behavior accounted for the most variation in decisions. Process level measures show little evidence of an initial bias to shoot Black suspects. Instead, results reveal a diminished ability to distinguish objects held by Black suspects. Conclusions This work emphasizes the importance of contextual factors in the decision to shoot and highlights how past experimental studies on racial bias have neglected critical inputs into officer deadly force decisions., The Emerging Imaging Technologies and Applications Laboratory (EITAL) is a shared resource serving as a proof-of-concept hub for performing innovative and rigorous fundamental cancer biology research at subcellular to cellular length-scales in conjunction with the development and translation of advanced imaging technologies and applications. The scientific staff of EITAL are experts in developing and improving reagents, methods, and optical and electron microscopic imaging technologies, antibody development, screening, and characterization, immunohistochemistry, immunocytochemistry, correlative optical and electron microscopy, immunoelectron microscopy, workflow development, and experimental design and data analysis of imaging studies. EITAL promotes synergies between its imaging technology developers and University of Kansas Cancer Center (KUCC) cancer biology researchers. EITAL also provides research training and career development programs to ensure a talented and diverse workforce engaged in cellular tumor cancer biology imaging research. The collaboration between EITAL and the University of Kansas (KU) Microscopy and Analytical Imaging Research Resource Core Laboratory (MAI) imaging scientists, enables imaging research at the level of the whole animal, individual cells, as well as molecules inside the cells, and provides instrumentation and expertise for optical and electron microscopies, resulting in multi-scale/multi-dimensional correlative imaging research of living and fixed cells and tissues. The KUCC Support Grant (P30 CA168524) supports EITAL., Introduction Sensorimotor integration deficits are common in Autism Spectrum Disorders (ASD). Evidence exists for an over-reliance on both visual and proprioceptive feedback during motor control in ASD, suggesting deficits in the modulation of sensory feedback processing and inability to use the most reliable input. This study aims to test this hypothesis. Methods Forty persons with ASD (10 – 33 yrs) and 25 age-, sex- and nonverbal IQ-matched controls completed precision gripping tasks. They squeezed a force sensor with their index finger and thumb and tried to match their force output to a target force. Visual feedback was presented on a computer screen across low, medium, and high gain levels; the force output bar moved a greater distance per change in force at higher gains. A stationary bar represented the target force. 80Hz tendon vibration was applied at the wrist to create a proprioceptive illusion of muscle contraction. Force regularity (approximate entropy; ApEn) was examined. Results Preliminary results from 18 participants with ASD and 13 controls indicate a Group × Tendon Vibration × Visual Gain interaction for ApEn (F = 1.559, p = 0.023). Controls showed increased ApEn during 80Hz tendon vibration at low visual gain but decreased ApEn with vibration at high visual gain. Individuals with ASD show slight increases in ApEn with 80Hz vibration across visual conditions. Conclusions Early findings indicate that controls shift to a secondary source of sensory feedback (e.g., proprioception) when the primary source (e.g., vision) is degraded. Persons with ASD fail to dynamically recalibrate feedback processes across sensory systems when feedback conditions change., Introduction African American women experience higher incidence and mortality rates of cervical and breast cancer. The purpose of this study is to develop and implement a breast and cervical cancer screening intervention to increase awareness, uptake of screening, and follow-up among an African American female church-population in Sedgwick County, Kansas. Methods Academic researchers recruited local pastors (N = 11) to develop a faith taskforce. Using intervention mapping, we conducted three focus groups with the taskforce to assess barriers and facilitators to seeking breast and cervical screenings and multi-component strategies to improve education and awareness of breast and cervical cancer screening recommendations, screening rates, and follow-up among African American women. Preliminary Results Of the 11 faith taskforce pastors, three were females. The key identified themes focused on barriers and facilitators to implementation of church-based cervical/breast cancer interventions, such as time constraints, limited expertise in conducting faith-based interventions, and lack of awareness on burden of cancer in the community, awareness of screening recommendations, and support/accountability in cancer screening and follow-up. Participants also indicated that a mobile phone app to track screenings, follow-up appointments, and promote education about risk factors and a church health navigator to assist with app utilization and track screenings and follow-up appointments would need to be primary intervention components. Conclusions Findings from the taskforce focus groups highlight the need for multi-component church-based interventions that include a mHealth app and church health navigators to improve awareness and adherence to breast/cervical cancer screening recommendations and follow-up among African American female church populations., Introduction Rituximab (RTX) is an effective maintenance therapy in forms of ANCA-associated vasculitis (AAV), specifically granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) (MAINRITSAN trial). Sixteen percent of patients will relapse despite RTX. Infliximab, an anti-chimeric antibody like RTX, is associated with a high rate of anti-drug antibody formation which effects its efficacy. The aims of this study are to a) evaluate the incidence of immunogenicity toward rituximab in AVV; and b) evaluate the relationship between anti-RTX antibodies and drug response. Herein we present the baseline data. Methods Inclusion criteria: a) meet either 1990 ACR and/or 2012 revised CHCC criteria for GPA or MPA; b) remission at entry; c) received Rituximab in last 12 months; d) plan to continue Rituximab; and e) no contraindications for receiving further RTX infusions. Results 30 participants (25 GPA and 5 MPA) were enrolled. ANCA by EIA was MPO positive in 14 (47%), PR3 positive in 13 (43%) and negative in 3 (10%). Mean age at enrollment was 62.5 years (IQR 46.5 – 67.5). 70% were female. The average immunoglobulin G (IgG) at baseline was 663 mg/dl (95% CI 566 – 760). 67% of participants had undetectable B-cells at baseline. Average time between the last Rituximab infusion and the first study Rituximab infusion was 34 weeks (95% CI 28 – 40 weeks). Conclusions At study baseline most of the participants were found to be B-cell depleted and mildly hypogammaglobulinemic. The average duration since the last Rituximab infusion at entry (8.5 months) was slightly longer than in the MAINRITSAN trial (six months)., Objective To determine safety and tolerability of two doses of ranolazine in patients with ALS and evaluate for preliminary evidence of drug-target engagement. Background Ranolazine, an FDA-approved drug for angina which inhibits the late Na+ current and intracellular Ca2+ accumulation, may be neuroprotective in ALS and reduce cramp frequency by reducing neuronal hyperexcitability. Design/Methods Open-label dose-ascending study of ranolazine with 12 participants in two sequential cohorts: 500 mg and 1,000 mg orally twice daily. Each has a two-week run-in period, four-week drug administration and six-week safety follow up. Primary outcome is the frequency of dose limiting toxicities and adverse events. Exploratory measures include cramp frequency and severity, fasciculation frequency (on ultrasound), cramp potential duration, ALS Functional Rating Scale-revised (ALSFRS-r), and forced vital capacity (FVC) compared from baseline to week six. Results The 10 currently enrolled patients (Cohort 1, n = 6; Cohort 2, n = 4) are mostly male (80%), and middle aged (median 53 years). There were no serious adverse events. One subject in cohort 2 discontinued the drug due to constipation. The most frequent drug-related adverse event was gastrointestinal (38%). Cramp frequency reduced by 44% (p = 0.01) and severity decreased by 36% (p = 0.002), with decreased awakening due to cramps and cramps interfering with daily activities or causing activity avoidance. Fasciculations, cramp potential duration, ALSFRS-r and FVC did not change. Conclusion Ranolazine was well tolerated in ALS up to 2,000 mg daily with gastrointestinal side effects being the most frequent. Ranolazine reduced cramp frequency and severity without significant effect on fasciculations, ALSFRS-r or FVC., Dietary intake of fruits and vegetables is consistently related to chronic disease risk. Unfortunately, measurement of fruit and vegetable intake is most often by self-report and thus, there are concerns about the validity of the data. The Veggie Meter (VM) uses Resonance Raman light scattering spectroscopy (RRS) to non-invasively measure skin carotenoid content. Skin carotenoids have recently been reported as a reproducible and valid biomarker for dietary intake of fruits and vegetables. In August of 2017, we purchased a VM and began using it in several studies. Due to demand, we were unable to accommodate all studies. Thus, in July 2018 Frontiers provided funds to purchase another VM. To date, we have used VM in seven completed pilot studies (six interventions and one observational study) and are using it in three ongoing studies. Specifically, the Frontiers-purchased machine is being used in two NIH-funded clinical trials. It is also used in community outreach events. The average age of individuals screened using this VM is 74.9 years and the VM score is 281.9 ± 70.1, indicating poor intake similar to the national average. Within 54 healthy older adults, VM scores correlated with intake of vegetables (r2 = 0.2, p = 0.001), fruits and vegetables (r2 = 0.15, p < 0.01), and four individual carotenoids (r2 > 0.18 & p < 0.01 for all) derived from self-reported 3-day food records. The VM is quick, non-invasive, and easy to use. It provides an objective measure of fruit and vegetable intake and will continue to be incorporated into our nutrition clinical trials and observational studies., Objective Greater cognitive function (CF) is associated with adherence to prescription medications, better program adherence and weight loss (WL) following bariatric surgery. The purpose of this study was to evaluate the association between baseline CF, intervention dropout, adherence and three-month WL. Methods One hundred and seven (Mean age = 40.9 yrs.), overweight/obese (BMI = 35.6 kg/m2) men (N = 17) and women (N = 90) completed a three-month WL intervention. Participants were asked to attend weekly behavioral sessions, comply with a reduced calorie diet and complete 100 min of moderate intensity physical activity (PA)/wk. CF tasks including Flanker (attention), Stroop (Executive control) and working memory, body weight and cardiovascular fitness (covariate) were assessed at baseline and three-months. Session attendance, adherence to PA and diet prescriptions and number of off-diet episodes were recorded weekly. Results Results indicated that attention was positively correlated with session attendance (p = 0.016), adherence to the diet (p < 0.01) and PA (p = 0.023). Executive control was positively correlated with WL (p = 0.042). Working memory (two tasks) was also positively correlated with WL (p = 0.017 and p = 0.025). Analysis of variance (ANOVA) indicated that baseline attention (p = 0.012) was positively related to WL and negatively associated with drop out (p < 0.05). Hierarchical linear regression showed executive control (p = 0.036, R2 = 0.054) and working memory (p = 0.013, R2 = 0.073 and p = 0.017, R2 = 0.068) were associated with WL when controlling for fitness. Significance These results suggest that stronger baseline attention is associated with completion of a three-month WL intervention. Executive control and working memory are associated with amount of WL achieved. Additional, larger and longer trials to assess the role of baseline CF on WL and evaluating the impact of interventions designed to improve CF on WL are indicated., Introduction Adolescent mothers are less likely to initiate and sustain exclusive or partial breastfeeding. About 70% of mothers under age 20 initiate breastfeeding, compared to 80% of 20 – 29-year-old mothers. Duration of breastfeeding to six months and one year by young mothers is 28% and 18%, compared to 48% and 28% in 20 – 29-year olds. Early breastfeeding experiences can adversely influence duration of breastfeeding. This study describes the early postpartum breastfeeding experiences among mothers 16 – 19 years of age. Methods This is a descriptive study within a larger pilot clinical trial. Four to eight weeks after giving birth, participants completed the Breastfeeding Experience Scale (BES), a 30-item measure which documents breastfeeding experiences, feeding patterns, and weaning. Severity of 18 early experiences are rated on a Likert type scale of 1 – 5 (1 = “not at all” to 5 = “unbearable”). Cronbach’s alpha for the 18-item summated scale of the BES was 0.80. Descriptive statistics characterized experiences for this in-progress study. Results Thirty breastfeeding participants, ages 16 – 19 (X = 17.97, SD = 0.96) completed the BES. Twenty-one (70%) were breastfeeding at time of survey and 57% were doing so exclusively. The most frequently reported breastfeeding problems were engorgement and leaking which were rated mild to moderate in severity (X = 2.97, SD = 1.03). Nine mothers (30%) weaned between 14 and 30 days after birth; engorgement, latching difficulty, and drop in milk supply were most common reasons. Conclusions Most teenage mothers in this sample maintained breastfeeding past one month after birth and reported few problems., Introduction Obesity affects ~14 million children/adolescents in the U.S. (8.9% of 2 – 5-year-olds; 17.5% of 6 – 11-year-olds) and increases the risk of developing type 2 diabetes (T2DM). Early metformin intervention may delay or halt progression to T2DM. However, clinical response to metformin in children with insulin resistance or T2DM is unpredictable. Additionally, no dosing recommendations exist for children < 10 years. Preliminary data show that clinical response to metformin may depend on the amount of metformin present in the body over time (systemic exposure), with maximum response observed at exposures = 30 mg/L*h. Modelling and simulations can help determine individualized doses to achieve this exposure, ideally achieving favorable response for every patient. This study aims to prospectively validate simulations of the metformin dose-exposure relationship in young children. Methods A 24-hour pharmacokinetic study (measuring systemic exposure) of 500 mg metformin in children (6 – 12 years) with IR. Pharmacokinetic simulations including individual parameters (e.g., sex, age, weight) were conducted for each subject using Simcyp, a physiologically-based pharmacokinetic simulator. Results Two out of 12 subjects have completed the research study: Subject 1: Female, 12 years, 158.6 cm, 70.2 kg, BMI: 97.44 percentile, HbA1C: 6.7%; simulation-recommended dose: 1750 mg. Subject 2: Male, 8 years, 134.9 cm, 36.5 kg. BMI 95.58 percentile, HbA1C: 6.5%; simulation-recommended dose: 1100 mg. Clinical pharmacokinetic data is not yet available. Conclusion Individualized doses of metformin may benefit young children with IR. Smaller/younger patients may require smaller doses of metformin than larger/older children; clinical pharmacokinetic data is needed to support simulation-guided individualized dosing., Introduction Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and has one of the worst one-year survival rates of any cancers. Understanding molecular mechanisms leading to HCC and developing novel strategies for effective prevention and treatment are urgent medical needs. HCC arises exclusively on the background of chronic liver injury and inflammation. Thus, an attractive therapeutic approach is to target key genes that regulate both inflammation and oncogenic pathways in HCC. RNA-binding protein Hu Antigen R (HuR) is one such candidate that controls the translation of multiple genes involved in inflammation and oncogenic process. The objective of this study is to characterize HuR targets in human HCC and test HuR-targeted intervention for HCC treatment. Methods HuR knockout (HuR-KO) in HCC cell line MHCC97H cells was accomplished by CRISPR/Cas9 gene editing system. The transcriptome comparison identified 1,516 differentially-expressed genes between HuR-KO cells and wild type controls. The top pathways altered by HuR knockout were cell proliferation, hippo signaling, beta integrin, pluripotent stem cells, EGFR, WNT, and FAK-PI3K-Akt-mTOR. To test HuR-targeted intervention for HCC treatment in vivo, MHCC97H cells were subcutaneously injected into athymic nude mice to establish HCC xenografts. Mice were then treated with a novel synthetic HuR inhibitor KH-3 for four weeks. Results and Conclusions Strikingly, KH-3 treatment significantly inhibited the growth of HCC xenografts. Taken together, our study provides a foundation for understanding the role of HuR in HCC. The mechanistic insights elucidated from our study may pave the way for developing therapeutic strategies to specifically target HuR for HCC treatment.
- Published
- 2020
48. Transient Impact of Automated Glomerular Filtration Rate Reporting on Drug Dosing for Hospitalized Older Adults With Concealed Renal Insufficiency
- Author
-
Kalender-Rich, Jessica L., Mahnken, Jonathan D., Wetmore, James B., and Rigler, Sally K.
- Published
- 2011
- Full Text
- View/download PDF
49. The relationship between beta‐amyloid accumulation and P3 event‐related potential in older adults: A pilot study
- Author
-
Devos, Hannes, primary, Gustafson, Kathleen, additional, Liao, Ke, additional, Ahmadnezhad, Pedram, additional, Brooks, William, additional, Mahnken, Jonathan D, additional, and Burns, Jeffrey M., additional
- Published
- 2021
- Full Text
- View/download PDF
50. The relationship between hippocampal volume and P3 event‐related potential in cognitively normal older adults without and with elevated amyloid: A pilot study
- Author
-
Devos, Hannes, primary, Brooks, William, additional, Gustafson, Kathleen, additional, Liao, Ke, additional, Ahmadnezhad, Pedram, additional, Mahnken, Jonathan D, additional, and Burns, Jeffrey M., additional
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.